Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis
about
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosisIncreased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.Systemic amyloidosis: novel therapies and role of biomarkers.New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac responseNew concepts in the treatment and diagnosis of amyloidosis.Serum copeptin and midregion proadrenomedullin (MR-proADM) after an ultramarathon.
P2860
Q28069975-26EB59E6-E739-4FB6-B8A9-48AADAA19EB5Q34091229-EAF85082-F3C7-4F90-95EA-7615D974D8ADQ38100987-1AD56988-1CF6-4CE7-AE38-255628007256Q38829923-3FAA6288-CC3C-4775-A146-459BA016D84AQ39024208-6A06EB2E-7921-450D-AA1B-BE1CAC357CF9Q39272596-8FF02141-A90B-46AC-BC89-CE4944F259A2Q47561519-42100B78-ACEF-4995-A74F-BBCDD15451DEQ54365449-DF82EB8C-7ABB-438E-8281-712C5C93A8B4
P2860
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis
description
im November 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 09 November 2011
@en
наукова стаття, опублікована в листопаді 2011
@uk
name
Midregional proadrenomedullin ...... early death in AL amyloidosis
@en
type
label
Midregional proadrenomedullin ...... early death in AL amyloidosis
@en
prefLabel
Midregional proadrenomedullin ...... early death in AL amyloidosis
@en
P2093
P2860
P50
P1433
P1476
Midregional proadrenomedullin ...... early death in AL amyloidosis
@en
P2093
Andrea Foli
Gabriele Sarais
Gian Vico Melzi d'Eril
Paola Russo
Remigio Moratti
Riccardo Albertini
Simona Casarini
P2860
P304
P356
10.3109/13506129.2011.627069
P50
P577
2011-11-09T00:00:00Z